Log In
Thursday 28th July 2016

GSK's HIV drug matches Merck

2nd April 2012

A new once-daily HIV drug developed by GSK is as good as Merck's twice-daily rival.

Click on available sources in right hand menu to see the original article.

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: GSK's HIV drug matches Merck
Author: Martine Hamilton
Article Id: 21563
Date Added: 2nd Apr 2012


Yahoo News

Recent Related Articles

Cancer drug approved

HIV treatment won't be offered in England

Cancer drug funding concern

HIV-infected organs successfully transplanted


Add to scrapbook
Show Comments
Add comment
Find all related articles


Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2016